Treating cancer with messenger RNA (mRNA) vaccines
16 June 2021
- mRNA vaccines have emerged more recently and have been headlined with the Pfizer-BioNTech and Moderna vaccines for COVID-19.
- Knowing exactly which mutations an individual’s cancer carries could allow scientists to develop mRNA vaccines specific to their particular cancer. Customising treatment in this way, whether for cancer or other diseases, is known as personalised medicine.
- “The great thing about mRNA vaccines are the manufacturing, scalability, and cost,” Dr. Kesari, Director of Neuro-oncology at Pacific Neuroscience Institute
Click here to learn more.
SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.
For more information, please visit www.svmpharma.com and contact us at email@example.com